This post has been archived and contains information that may be out of date.
The Drug Enforcement Administration and the Substance Abuse and Mental Health Services Administration has extended its COVID-19 pandemic rules for prescribing controlled substances via telemedicine through Dec. 31, 2024. The regulation is effective Nov. 11.
This is the second extension of these rules. The agencies’ first extension is set to expire in Nov. 2024. This extension allows the telehealth prescribing flexibilities that were adopted during the COVID-19 public health emergency (PHE) to remain in effect past the end of the PHE while the agencies develop final regulations.
